Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|August 25, 2006
[Clinical features of neuroendocrine tumor of the pancreas: single center study]Tae Wook Kang, Kyu Taek Lee, Min Kyu Ryu, et al.
Annals of Coloproctology|May 7, 2024
Comparing the efficacy of combined versus single immune cell adaptive therapy targeting colorectal cancerDenis Nchang Che, NaHye Lee, Hyo-Jung Lee, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2007
A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinomaByeong-Bae Park, Joon Oh Park, Hyo Rak Lee, et al.
Clinical and Translational Radiation Oncology|February 6, 2024
Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapyKangpyo Kim, Hee Chul Park, Jeong Il Yu, et al.
Cancer Chemotherapy and Pharmacology|September 9, 2017
Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in KoreaKyong Joo Lee, Jae Hee Cho, Sang Hyub Lee, et al.
Cancers|July 2, 2021
Accurate Prognosis Prediction of Pancreatic Ductal Adenocarcinoma Using Integrated Clinico-Genomic Data of Endoscopic Ultrasound-Guided Fine Needle BiopsyJoo Kyung Park, Hyemin Kim, Dae-Soon Son, et al.
Proteomics|October 16, 2012
Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinomaHyung-Doo Park, Eun-Suk Kang, Jong-Won Kim, et al.
Scientific Reports|July 25, 2018
Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinomaWon-Suk Song, Hae-Min Park, Jung Min Ha, et al.
Oncology|June 25, 2011
A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic cancerJun Ho Yi, Jeeyun Lee, Se Hoon Park, et al.
Cancer Chemotherapy and Pharmacology|October 8, 2008
Irinotecan monotherapy as second-line treatment in advanced pancreatic cancerSeong Yoon Yi, Young Suk Park, Hyo Song Kim, et al.
Pageof 20